1.51
Schlusskurs vom Vortag:
$1.49
Offen:
$1.5
24-Stunden-Volumen:
231.12K
Relative Volume:
0.77
Marktkapitalisierung:
$79.35M
Einnahmen:
$1.82M
Nettoeinkommen (Verlust:
$-267.63M
KGV:
-0.0749
EPS:
-20.1639
Netto-Cashflow:
$-50.53M
1W Leistung:
-5.63%
1M Leistung:
-46.83%
6M Leistung:
-48.99%
1J Leistung:
-82.60%
Cibus Inc Stock (CBUS) Company Profile
Firmenname
Cibus Inc
Sektor
Branche
Telefon
(858) 450-0008
Adresse
6455 NANCY RIDGE DRIVE, SAN DIEGO
Vergleichen Sie CBUS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CBUS
Cibus Inc
|
1.51 | 79.35M | 1.82M | -267.63M | -50.53M | -20.16 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-29 | Eingeleitet | Alliance Global Partners | Buy |
2024-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
2023-07-19 | Fortgesetzt | Canaccord Genuity | Buy |
Cibus Inc Aktie (CBUS) Neueste Nachrichten
Cibus and John Innes Centre announce ongoing collaboration with potential to revolutionise fertilizer use in farming - World Fertilizer
Financial Metrics Exploration: Understanding Cibus Inc (CBUS) Through Ratios - DWinneX
Two Sigma Investments LP Purchases New Holdings in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus Slides on Alliance with John Innes Centre - Baystreet.ca
Cibus (CBUS) Expands Collaboration with John Innes Centre for Cr - GuruFocus
Cibus (CBUS) Expands Collaboration with John Innes Centre for Crop Innovation | CBUS Stock News - GuruFocus
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming - The Manila Times
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize ... - Leader-Telegram
Agricultural Breakthrough: Scientists Find Gene Mutation That Could Transform Farming Economics - Stock Titan
USDA-APHIS Designates Cibus's Herbicide Tolerance Canola Trait HT2 as Not Regulated - ISAAA.org
Millennium Management LLC Sells 15,409 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus, Inc. Announces Closing of $27.5 Million Public Offering | - GuruFocus
Cibus, Inc. Announces Closing of $27.5 Million Public Offering - The Manila Times
Cibus, Inc. Closes $27.5 Million Public Offering of Class A Common Stock - Nasdaq
Agricultural Biotech Cibus Secures $27.5M Investment to Advance Gene Editing Platform - Stock Titan
CBUS ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cibus, Inc. Shareholders Who Lost Money - ACCESS Newswire
Hogs Look to New Week Following Friday Strength - The Globe and Mail
Jane Street Group LLC Takes Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus says USDA designates HT2 as ‘not regulated’ under biotech regulations - Yahoo Finance
Nuveen Asset Management LLC Has $106,000 Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus Canola Trait Gains USDA Non-Regulated Status By Investing.com - Investing.com South Africa
Cibus Announces Public Offering of Common Stock - TipRanks
Cibus Stock (CBUS) Plummets 30% on Public Offering Pricing - The Globe and Mail
Cibus stock rises on USDA deregulation of new canola trait By Investing.com - Investing.com Nigeria
Cibus stock rises on USDA deregulation of new canola trait - Investing.com Australia
Cibus Canola Trait Gains USDA Non-Regulated Status - Investing.com Australia
Cibus (CBUS) Gains USDA Approval for New Herbicide Tolerance Tra - GuruFocus
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as N - GuruFocus
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations | CBUS Stock News - GuruFocus
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations - The Manila Times
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s ... - Leader-Telegram
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s Biotechnology Regulations - TradingView
Breakthrough: USDA Greenlights Cibus Revolutionary Herbicide Resistance Technology for Global Canola Market - Stock Titan
Public market insider selling at Dye & Durham (DND) - The Globe and Mail
Cibus sets price for $27.5 million stock offering By Investing.com - Investing.com India
Stocks Dive After Key Announcements From Helius, Mullen, And Cibus - Finimize
Cibus Prices $27.5 Mln Public Offering To Advance Gene-Edited Rice Traits - Nasdaq
Canaccord Genuity lowers Cibus stock price target after equity raise By Investing.com - Investing.com South Africa
Canaccord Genuity lowers Cibus stock price target after equity raise - Investing.com
Cibus announces pricing of $27.5M public offering - MSN
Cibus announces pricing of $27.5 million public offering - MSN
Cibus stock plummets following offering price of $1.75 per share By Investing.com - Investing.com South Africa
Cibus stock plummets following offering price of $1.75 per share - Investing.com Australia
Cibus sets price for $27.5 million stock offering - Investing.com Australia
Cibus (CBUS) Prices Public Offering to Raise $27.5M | CBUS Stock News - GuruFocus
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering - The Manila Times
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering | - GuruFocus
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering | CBUS Stock News - GuruFocus
Finanzdaten der Cibus Inc-Aktie (CBUS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cibus Inc-Aktie (CBUS) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Prante Gerhard | Director |
Feb 24 '25 |
Sale |
2.07 |
1,150 |
2,380 |
8,857 |
Prante Gerhard | Director |
Feb 21 '25 |
Sale |
2.20 |
1,150 |
2,530 |
10,007 |
Prante Gerhard | Director |
Feb 20 '25 |
Sale |
2.35 |
1,150 |
2,702 |
11,157 |
Prante Gerhard | Director |
Feb 19 '25 |
Sale |
2.58 |
1,150 |
2,967 |
12,307 |
Prante Gerhard | Director |
Feb 18 '25 |
Sale |
2.52 |
2,300 |
5,796 |
13,457 |
Prante Gerhard | Director |
Feb 14 '25 |
Sale |
2.60 |
1,150 |
2,990 |
15,757 |
Prante Gerhard | Director |
Feb 13 '25 |
Sale |
2.53 |
1,150 |
2,910 |
16,907 |
Prante Gerhard | Director |
Feb 12 '25 |
Sale |
2.45 |
1,150 |
2,818 |
18,057 |
Prante Gerhard | Director |
Feb 11 '25 |
Sale |
2.48 |
1,150 |
2,852 |
19,207 |
Prante Gerhard | Director |
Feb 10 '25 |
Sale |
2.52 |
1,150 |
2,898 |
20,357 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):